CD71 binding fibronectin type III domains
Grant
US12589159B2
Kind: B2
Mar 31, 2026
Assignee
ARO Biotherapeutics Company
Inventors
Russell C. Addis, Zhanna Druzina, Robert Kolakowski, Swapnil Kulkarni, Steven G. Nadler, Karyn O'Neil, Yao Xin
Abstract
The present disclosure relates to polypeptides, such as fibronectin type III (FN3) domains that can bind CD71, their conjugates, isolated nucleotides encoding the molecules, vectors, host-cells, as well as methods of making and using the same.
CPC Classifications
C12N 2320/32
C12N 2310/14
C12N 2310/3513
C12N 2310/11
C12N 15/113
A61K 47/6435
A61K 31/7088
C07K 14/435
Filing Date
2023-02-27
Application No.
18174751
Claims
18